Clinical trials: Gut Biome
DLBCL, Glofitamab
Gut Microbiome in DLBCL Treated With Glofitamab
The gut microbiome (GM) has recently emerged as one of the key modifiable factors of response and prognosis to immunotherapy in cancer patients.
- Conditions
- DLBCL, Glofitamab, Gut Biome
- Trial name
- NCT07498920
- Testing
- Gut microbiome analysis
- Volunteers
- 30 people
- Sponsor
- Peking Union Medical College Hospital
Asthma in Children
A Clinical Trial of Soluble Fiber for Asthma
Randomized controlled trial of soluble fiber (Fruitafit Inulin). Participants will complete an ASA 24 dietary recall questionnaire to access their fiber intake.
- Trial name
- NCT06372249
- Testing
- Inulin
- Where
- United States
- Volunteers
- 105 people
- Sponsor
- Phoenix Children's Hospital